GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Middle East Pharmaceutical Industries Co (SAU:4016) » Definitions » Asset Turnover

Middle East Pharmaceutical Industries Co (SAU:4016) Asset Turnover : 0.38 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Middle East Pharmaceutical Industries Co Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Middle East Pharmaceutical Industries Co's Revenue for the six months ended in Jun. 2024 was ﷼177.0 Mil. Middle East Pharmaceutical Industries Co's Total Assets for the quarter that ended in Jun. 2024 was ﷼466.0 Mil. Therefore, Middle East Pharmaceutical Industries Co's Asset Turnover for the quarter that ended in Jun. 2024 was 0.38.

Asset Turnover is linked to ROE % through Du Pont Formula. Middle East Pharmaceutical Industries Co's annualized ROE % for the quarter that ended in Jun. 2024 was 18.49%. It is also linked to ROA % through Du Pont Formula. Middle East Pharmaceutical Industries Co's annualized ROA % for the quarter that ended in Jun. 2024 was 13.38%.


Middle East Pharmaceutical Industries Co Asset Turnover Historical Data

The historical data trend for Middle East Pharmaceutical Industries Co's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Middle East Pharmaceutical Industries Co Asset Turnover Chart

Middle East Pharmaceutical Industries Co Annual Data
Trend
Asset Turnover

Middle East Pharmaceutical Industries Co Semi-Annual Data
Jun23 Jun24
Asset Turnover - 0.38

Competitive Comparison of Middle East Pharmaceutical Industries Co's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Middle East Pharmaceutical Industries Co's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Middle East Pharmaceutical Industries Co's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Middle East Pharmaceutical Industries Co's Asset Turnover falls into.



Middle East Pharmaceutical Industries Co Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Middle East Pharmaceutical Industries Co's Asset Turnover for the fiscal year that ended in . 20 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
=

Middle East Pharmaceutical Industries Co's Asset Turnover for the quarter that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=176.952/( (0+465.958)/ 1 )
=176.952/465.958
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Middle East Pharmaceutical Industries Co  (SAU:4016) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Middle East Pharmaceutical Industries Co's annulized ROE % for the quarter that ended in Jun. 2024 is

ROE %**(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=62.35/337.154
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(62.35 / 353.904)*(353.904 / 465.958)*(465.958/ 337.154)
=Net Margin %*Asset Turnover*Equity Multiplier
=17.62 %*0.7595*1.382
=ROA %*Equity Multiplier
=13.38 %*1.382
=18.49 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Middle East Pharmaceutical Industries Co's annulized ROA % for the quarter that ended in Jun. 2024 is

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=62.35/465.958
=(Net Income / Revenue)*(Revenue / Total Assets)
=(62.35 / 353.904)*(353.904 / 465.958)
=Net Margin %*Asset Turnover
=17.62 %*0.7595
=13.38 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Middle East Pharmaceutical Industries Co Asset Turnover Related Terms

Thank you for viewing the detailed overview of Middle East Pharmaceutical Industries Co's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Middle East Pharmaceutical Industries Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Website
Middle East Pharmaceutical Industries Co is a holding company is engaged in manufacturing medicines, medicated and non-medicated creams and gels.

Middle East Pharmaceutical Industries Co Headlines

No Headlines